Bausch + Lomb Names Robert Bertolini President and Chief Financial Officer

By
ROCHESTER, NY — Bausch + Lomb has named Robert Bertolini as president and chief financial officer, effective immediately. In this capacity, he will oversee the company’s Finance, Information Technology and Global Quality and Operations (GQO) functions, according to an announcement from Bausch + Lomb. Bertolini, who assumes CFO responsibilities from Brian J. Harris, will report to Bausch + Lomb’s chief executive officer, Brent Saunders.

“Bob Bertolini’s extensive strategic, operational and transformative leadership experience as a CFO of one of the world’s leading publicly traded health care companies will enable Bausch + Lomb to further unlock our potential and accelerate our performance,” said Saunders. “I’ve had the opportunity to work closely with Bob over many years. We are gratified to have an executive of his caliber join our team at this pivotal period in our history.”

Bertolini’s broad-based experience and deep knowledge of business operations and strategy have consistently enabled the companies he has been involved with to improve overall performance and accelerate business results, B+L said.

“Under Brent’s leadership, Bausch + Lomb has made tremendous progress over the last few years, and I’m looking forward to working with him and the entire Bausch + Lomb management team to take the company to the next level,” said Bertolini. “We have a compelling opportunity to realize Bausch + Lomb’s vision of becoming the best global eye health company, for our customers and the patients they serve. I am excited and honored to become part of this team.”

Previously, Bertolini was executive vice president and chief financial officer at Schering-Plough Corporation from 2003 until its merger with Merck & Co. in 2009. During his tenure, Bertolini worked as a business partner with the chief executive officer in all aspects of transforming the company's operations. Earlier in his career, Bertolini spent 20 years at PricewaterhouseCoopers LLP, where he held positions of increasing responsibility, ultimately becoming partner and leading the Global Pharmaceutical Industry practice.

“Brian Harris has contributed to Bausch + Lomb in so many ways, and I want to thank him for his outstanding service to date,” said Saunders. “As a result of Brian’s great work, we’re exploring the possibility of having him take on a different senior leadership role at Bausch + Lomb.”